| 000 | 00926 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516014355.0 | ||
| 264 | 0 | _c20121002 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1862-8354 | ||
| 024 | 7 |
_a10.1002/prca.200800222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJenkins, Rosalind E | |
| 245 | 0 | 0 |
_aCharacterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo. _h[electronic resource] |
| 260 |
_bProteomics. Clinical applications _cJun 2009 |
||
| 300 |
_a720-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aMeng, Xiaoli | |
| 700 | 1 | _aElliott, Victoria L | |
| 700 | 1 | _aKitteringham, Neil R | |
| 700 | 1 | _aPirmohamed, Munir | |
| 700 | 1 | _aPark, B Kevin | |
| 773 | 0 |
_tProteomics. Clinical applications _gvol. 3 _gno. 6 _gp. 720-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/prca.200800222 _zAvailable from publisher's website |
| 999 |
_c20427800 _d20427800 |
||